Carlsbad, CA, United States of America

Michael Chobotov

This inventor holds 1 USPTO granted patent. Top assignee: Endologix, Inc.. Active years: 2023.


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Michael Chobotov in Vascular Repair

Introduction

Michael Chobotov is an accomplished inventor based in Carlsbad, CA (US). He has made significant contributions to the field of medical devices, particularly in the area of vascular repair. His innovative approach has led to the development of a unique system designed to enhance the effectiveness of blood vessel repairs.

Latest Patents

Michael Chobotov holds a patent for "Systems and methods with anchor device for fixation of filling structures in blood vessels." This patent describes a system that includes an anchor device featuring a stent and a suture loop that connects the distal end portions of the stent. The system allows for the insertion of filling structures through the suture loop into the stent when it is in an expanded state. The design ensures that portions of the filling structures protrude through openings in the anchor device, creating a seal against the blood vessel wall. This innovative method facilitates the repair of one or more blood vessels effectively.

Career Highlights

Michael Chobotov is associated with Endologix, Inc., a company known for its advancements in vascular therapies. His work at Endologix has been pivotal in developing solutions that improve patient outcomes in vascular health. His dedication to innovation in this field has established him as a notable figure among inventors.

Collaborations

Due to space constraints, the details of collaborations will not be included.

Conclusion

Michael Chobotov's contributions to vascular repair through his patented innovations demonstrate his commitment to improving medical technology. His work continues to influence the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…